Literature DB >> 22835577

Strategies for the care of adults hospitalized for active ulcerative colitis.

Suresh Pola1, Derek Patel, Sonia Ramamoorthy, Elisabeth McLemore, Marianne Fahmy, Jesus Rivera-Nieves, John T Chang, Elisabeth Evans, Michael Docherty, Mark Talamini, William J Sandborn.   

Abstract

Ulcerative colitis is a chronic inflammatory disease of the colon; as many as 25% of patients with this disease require hospitalization. The goals of hospitalization are to assess disease severity, exclude infection, administer rapidly acting and highly effective medication regimens, and determine response. During hospitalization, patients should be given venous thromboembolism prophylaxis and monitored for the development of toxic megacolon. Patients who do not respond to intravenous corticosteroids should be considered for rescue therapy with infliximab or cyclosporine. Patients who are refractory to medical therapies or who develop toxic megacolon should be evaluated promptly for colectomy. Patients who do respond to medical therapies should be discharged on an appropriate maintenance regimen when they meet discharge criteria. We review practical evidence-based management principles and propose a day-by-day algorithm for managing patients hospitalized for ulcerative colitis.
Copyright © 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22835577      PMCID: PMC4226798          DOI: 10.1016/j.cgh.2012.07.006

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  101 in total

1.  Out-patient treatment of ulcerative colitis. Comparison between three doses of oral prednisone.

Authors:  J H BARON; A M CONNELL; T G KANAGHINIS; J E LENNARD-JONES; A F JONES
Journal:  Br Med J       Date:  1962-08-18

2.  Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee.

Authors:  Asher Kornbluth; David B Sachar
Journal:  Am J Gastroenterol       Date:  2010-01-12       Impact factor: 10.864

3.  An experience of ulcerative colitis. I. Toxic dilation in 55 cases.

Authors:  K N Jalan; W Sircus; W I Card; C W Falconer; C B Bruce; G P Crean; J P McManus; W P Small; A N Smith
Journal:  Gastroenterology       Date:  1969-07       Impact factor: 22.682

4.  Treatment of hospitalized adult patients with severe ulcerative colitis: Toronto consensus statements.

Authors:  Alain Bitton; Donald Buie; Robert Enns; Brian G Feagan; Jennifer L Jones; John K Marshall; Scott Whittaker; Anne M Griffiths; Remo Panaccione
Journal:  Am J Gastroenterol       Date:  2011-11-22       Impact factor: 10.864

5.  Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study.

Authors:  Matthew J Grainge; Joe West; Timothy R Card
Journal:  Lancet       Date:  2010-02-08       Impact factor: 79.321

6.  Postoperative complications and mortality following colectomy for ulcerative colitis.

Authors:  Shanika de Silva; Christopher Ma; Marie-Claude Proulx; Marcelo Crespin; Belle S Kaplan; James Hubbard; Martin Prusinkiewicz; Andrew Fong; Remo Panaccione; Subrata Ghosh; Paul L Beck; Anthony Maclean; Donald Buie; Gilaad G Kaplan
Journal:  Clin Gastroenterol Hepatol       Date:  2011-07-30       Impact factor: 11.382

7.  GI distension in severe ulcerative colitis.

Authors:  Giovanni Latella; Piero Vernia; Angelo Viscido; Giuseppe Frieri; Giuseppina Cadau; Andrea Cocco; Andrea Cossu; Ernesto Tomei; Renzo Caprilli
Journal:  Am J Gastroenterol       Date:  2002-05       Impact factor: 10.864

8.  Ciclosporin use in acute ulcerative colitis: a long-term experience.

Authors:  Simon Campbell; Simon Travis; Derek Jewell
Journal:  Eur J Gastroenterol Hepatol       Date:  2005-01       Impact factor: 2.566

9.  Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis.

Authors:  Gert Van Assche; Geert D'Haens; Maja Noman; Séverine Vermeire; Martin Hiele; Katrien Asnong; Joris Arts; Andre D'Hoore; Freddy Penninckx; Paul Rutgeerts
Journal:  Gastroenterology       Date:  2003-10       Impact factor: 22.682

10.  Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis.

Authors:  Chelliah R Selvasekar; Robert R Cima; David W Larson; Eric J Dozois; Jeffrey R Harrington; William S Harmsen; Edward V Loftus; William J Sandborn; Bruce G Wolff; John H Pemberton
Journal:  J Am Coll Surg       Date:  2007-05       Impact factor: 6.113

View more
  14 in total

1.  Day-by-Day Management of the Inpatient With Moderate to Severe Inflammatory Bowel Disease.

Authors:  Sara Lewin; Fernando S Velayos
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-09

2.  The Writing Is on the Wall: The Utility of Mural Stratification for Risk Stratification of Hospitalized Patients with Severe Ulcerative Colitis.

Authors:  Georgios I Tsiaoussis; Stelios F Assimakopoulos; Konstantinos C Thomopoulos
Journal:  Dig Dis Sci       Date:  2019-08       Impact factor: 3.199

3.  Hospital Management of Acute Severe Ulcerative Colitis.

Authors:  Joseph Feuerstein
Journal:  Gastroenterol Hepatol (N Y)       Date:  2021-03

4.  Management of Hospitalized Patients With Ulcerative Colitis.

Authors:  Leonard Baidoo
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-03

5.  Effect of Accelerated Infliximab Induction on Short- and Long-term Outcomes of Acute Severe Ulcerative Colitis: A Retrospective Multicenter Study and Meta-analysis.

Authors:  Niharika Nalagatla; Katherine Falloon; Gloria Tran; Nienke Z Borren; Danny Avalos; Jay Luther; Francis Colizzo; John Garber; Hamed Khalili; Joanna Melia; Matthew Bohm; Ashwin N Ananthakrishnan
Journal:  Clin Gastroenterol Hepatol       Date:  2018-06-23       Impact factor: 11.382

6.  Impact of Specialized Inpatient IBD Care on Outcomes of IBD Hospitalizations: A Cohort Study.

Authors:  Cindy C Y Law; Saranya Sasidharan; Rodrigo Rodrigues; Deanna D Nguyen; Jenny Sauk; John Garber; Cosmas Giallourakis; Ramnik Xavier; Hamed Khalili; Vijay Yajnik; Ashwin N Ananthakrishnan
Journal:  Inflamm Bowel Dis       Date:  2016-09       Impact factor: 5.325

7.  Opportunities for Improvement in the Care of Patients Hospitalized for Inflammatory Bowel Disease-Related Colitis.

Authors:  Noel S Lee; Suresh Pola; Erik J Groessl; Jesus Rivera-Nieves; Samuel B Ho
Journal:  Dig Dis Sci       Date:  2016-02-10       Impact factor: 3.199

8.  Delayed Initiation of Rescue Therapy Associated with Increased Length of Stay in Acute Severe Ulcerative Colitis.

Authors:  Alyssa Caplan; Ryan McConnell; Fernando Velayos; Uma Mahadevan; Sara Lewin
Journal:  Dig Dis Sci       Date:  2022-04-07       Impact factor: 3.199

Review 9.  Contemporary Management of Ulcerative Colitis.

Authors:  Rohini Vanga; Millie D Long
Journal:  Curr Gastroenterol Rep       Date:  2018-03-27

10.  Adjuvant use of antibiotics with corticosteroids in inflammatory bowel disease exacerbations requiring hospitalisation: a retrospective cohort study and meta-analysis.

Authors:  V Gupta; R Rodrigues; D Nguyen; J Sauk; H Khalili; V Yajnik; A N Ananthakrishnan
Journal:  Aliment Pharmacol Ther       Date:  2015-11-05       Impact factor: 8.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.